Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business
Stay Pausing Investments
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world’s top 15 biopharmaceutical companies in terms of oncology sales.
Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business
Stay Pausing InvestmentsContinues serving patients. March 29, 2022 "In line with our relentless commitment to serving patients, we will continue to tackle their healthcare needs regardless of their race, sex, nationality, ethnicity, country of origin, language, or religion. We support global sanctions, and we will take all precautionary measures to comply with them. We have suspended several promotional activities in Russia, including advertising and participation to non-scientific congresses. Additionally, we will not initiate any new clinical trials."